H-SIITFEKL-OH

Ref. 3D-PP46009

Información del producto

• Nombre: H-SIITFEKL-OH
• Sinónimos: NH2-Ser-Ile-Ile-Thr-Phe-Glu-Lys-Leu-OH

Descripción

Peptide H-SIITFEKL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-SIITFEKL-OH include the following: Sodium Butyrate Promotes CD8 T Cell Response to Low Affinity Ligand Z Yu, Y Zhao, F Li, G Chen, L Zhang - Proceedings of the Fourth , 2020 - dl.acm.orghttps://dl.acm.org/doi/abs/10.1145/3403782.3403788 Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletion Y Hailemichael , Z Dai, N Jaffarzad, Y Ye, MA Medina - Nature medicine, 2013 - nature.comhttps://www.nature.com/articles/nm.3105 Hyaluronan-binding by CD44 reduces the memory potential of activated murine CD8 T cells SSM Lee-Sayer, N Maeshima - European Journal of , 2018 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.201747263 Universal antigen encoding of T cell activation from high-dimensional cytokine dynamics SR Achar , FXP Bourassa , TJ Rademaker , A Lee - Science, 2022 - science.orghttps://www.science.org/doi/abs/10.1126/science.abl5311 Interferon regulatory factor 4 sustains CD8+ T cell expansion and effector differentiation S Yao, BF Buzo, D Pham , L Jiang, EJ Taparowsky - Immunity, 2013 - cell.comhttps://www.cell.com/immunity/pdf/S1074-7613(13)00466-4.pdf IRF4 modulates CD8+ T cell sensitivity to IL-2 family cytokines S Huang, Y Shen, D Pham , L Jiang, Z Wang - , 2017 - journals.aai.orghttps://journals.aai.org/immunohorizons/article/1/6/92/3761 Autoreactive T cells bypass negative selection and respond to self-antigen stimulation during infection S Enouz, L Carrie, D Merkler , MJ Bevan - Journal of Experimental , 2012 - rupress.orghttps://rupress.org/jem/article-abstract/209/10/1769/41219 The tyrosine phosphatase PTPN22 discriminates weak self peptides from strong agonist TCR signals RJ Salmond , RJ Brownlie, VL Morrison - Nature , 2014 - nature.comhttps://www.nature.com/articles/ni.2958 Mechanistic target of rapamycin complex 1/S6 kinase 1 signals influence T cell activation independently of ribosomal protein S6 phosphorylation RJ Salmond , RJ Brownlie, O Meyuhas - The Journal of , 2015 - journals.aai.orghttps://journals.aai.org/jimmunol/article/195/10/4615/104772 Resistance to TGFbeta suppression and improved anti-tumor responses in CD8+ T cells lacking PTPN22 RJ Brownlie, C Garcia, M Ravasz, D Zehn - Nature , 2017 - nature.comhttps://www.nature.com/articles/s41467-017-01427-1 IL-12-mediated STAT4 signaling and TCR signal strength cooperate in the induction of CD40L in human and mouse CD8+ T cells R Stark, A Hartung, D Zehn - European journal of , 2013 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.201243218 Hierarchy of signaling thresholds downstream of the T cell receptor and the Tec kinase ITK MP Gallagher, JM Conley, P Vangala - Proceedings of the , 2021 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.2025825118 The Tec kinase ITK differentially optimizes NFAT, NF-κB, and MAPK signaling during early T cell activation to regulate graded gene induction MP Gallagher, JM Conley, P Vangala , A Reboldi - bioRxiv, 2020 - biorxiv.orghttps://www.biorxiv.org/content/10.1101/2020.11.12.380725.abstract Mammalian target of rapamycin complex 2 controls CD8 T cell memory differentiation in a Foxo1-dependent manner L Zhang , BO Tschumi, IC Lopez-Mejia , SG Oberle - Cell reports, 2016 - cell.comhttps://www.cell.com/cell-reports/pdf/S2211-1247(15)01551-X.pdf Direct in vivo activation of T cells with nanosized immunofilaments inhibits tumor growth and metastasis L Weiss, J Weiden, Y Dölen, EM Grad - Acs Nano, 2023 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acsnano.2c11884 Immunofilaments Provide a Nanoscale Platform for In Vivo T Cell Expansion and Cancer Immunotherapy L Weiss, J Weiden, Y Dölen, EM Grad - bioRxiv, 2022 - biorxiv.orghttps://www.biorxiv.org/content/10.1101/2022.10.14.512109.abstract The microtubule-depolymerizing agent ansamitocin P3 programs dendritic cells toward enhanced anti-tumor immunity K Martin, P Muller, J Schreiner, SS Prince - Cancer Immunology , 2014 - Springerhttps://link.springer.com/article/10.1007/s00262-014-1565-4 The impact of TCR signal strength on resident memory T cell formation during influenza virus infection JK Fiege , IA Stone , EJ Fay, MW Markman - The Journal of , 2019 - journals.aai.orghttps://journals.aai.org/jimmunol/article/203/4/936/109968 MicroRNA-155 is required for effector CD8+ T cell responses to virus infection and cancer JC Dudda, B Salaun, Y Ji, DC Palmer, GC Monnot - Immunity, 2013 - cell.comhttps://www.cell.com/immunity/pdf/S1074-7613(13)00152-0.pdf TGFbeta limits Myc-dependent TCR-induced metabolic reprogramming in CD8+ T cells HC Hope, G Pickersgill, P Ginefra , N Vannini - Frontiers in , 2022 - frontiersin.orghttps://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.913184 Zfp36l1 establishes the high-affinity CD8 T-cell response by directly linking TCR affinity to cytokine sensing G Petkau , TJ Mitchell, MJ Evans - European Journal of , 2024 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.202350700 Apoptosis threshold set by Noxa and Mcl-1 after T cell activation regulates competitive selection of high-affinity clones FM Wensveen , KPJM van Gisbergen , IAM Derks - Immunity, 2010 - cell.comhttps://www.cell.com/immunity/pdf/S1074-7613(10)00208-6.pdf Survival of the fittest clone: Pro-apoptotic protein Noxa controls selection of lymphocytes under competitive conditions FM Wensveen - 2010 - dare.uva.nlhttps://dare.uva.nl/document/2/81778 Distinct PKC-mediated posttranscriptional events set cytokine production kinetics in CD8+ T cells F Salerno, NA Paolini, R Stark - Proceedings of the , 2017 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.1704227114 Costimulation through TLR2 drives polyfunctional CD8+ T cell responses F Salerno, JJ Freen-van Heeren , A Guislain - The Journal of , 2019 - journals.aai.orghttps://journals.aai.org/jimmunol/article/202/3/714/107298 Phosphoinositide 3-kinase ÎŽ inhibition promotes antitumor responses but antagonizes checkpoint inhibitors EL Lim , FM Cugliandolo, DR Rosner, D Gyori - JCI insight, 2018 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6124416/ Autoimmunity-associated LYP-W620 does not impair thymic negative selection of autoreactive T cells DJ Wu , W Zhou, S Enouz, V Orru , SM Stanford - PLoS , 2014 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0086677 Deletion of the protein tyrosine phosphatase PTPN22 for adoptive T cell therapy facilitates CTL effector function but promotes T cell exhaustion AR Teagle, P Castro-Sanchez - for immunotherapy of , 2023 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10711921/ Role of tyrosine phosphatase PTPN22 in CTL responses to tumours and T cell exhaustion AR Teagle - 2024 - era.ed.ac.ukhttps://era.ed.ac.uk/handle/1842/41596 Recruitment of epitope-specific T cell clones with a low-avidity threshold supports efficacy against mutational escape upon re-infection A Straub, S Grassmann , S Jarosch, L Richter - Immunity, 2023 - cell.comhttps://www.cell.com/immunity/pdf/S1074-7613(23)00179-6.pdf Generation of affinity ranged antigen-expressing tumor cell lines A Martinez-Usatorre, P Romero - Methods in enzymology, 2020 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0076687919304781 PD-1 blockade unleashes effector potential of both high-and low-affinity tumor-infiltrating T cells A Martaca­nez-Usatorre, A Donda, D Zehn - The Journal of , 2018 - journals.aai.orghttps://journals.aai.org/jimmunol/article/201/2/792/111869 PD-1 limits differentiation and plasticity of Tc17 cells A Arra, H Lingel, M Pierau - Frontiers in , 2023 - frontiersin.orghttps://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2023.1104730

• Marca: Biosynth